ATE401337T1 - Antiangiogene polypeptide - Google Patents

Antiangiogene polypeptide

Info

Publication number
ATE401337T1
ATE401337T1 AT01987119T AT01987119T ATE401337T1 AT E401337 T1 ATE401337 T1 AT E401337T1 AT 01987119 T AT01987119 T AT 01987119T AT 01987119 T AT01987119 T AT 01987119T AT E401337 T1 ATE401337 T1 AT E401337T1
Authority
AT
Austria
Prior art keywords
polypeptides
antiangiogenic polypeptides
antiangiogenic
disclosed
methods
Prior art date
Application number
AT01987119T
Other languages
English (en)
Inventor
David M Waisman
Geetha Kassam
Mijung Kwon
Original Assignee
David M Waisman
Geetha Kassam
Mijung Kwon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David M Waisman, Geetha Kassam, Mijung Kwon filed Critical David M Waisman
Application granted granted Critical
Publication of ATE401337T1 publication Critical patent/ATE401337T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT01987119T 2000-11-28 2001-11-28 Antiangiogene polypeptide ATE401337T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25372500P 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
ATE401337T1 true ATE401337T1 (de) 2008-08-15

Family

ID=22961462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987119T ATE401337T1 (de) 2000-11-28 2001-11-28 Antiangiogene polypeptide

Country Status (8)

Country Link
US (2) US7420036B2 (de)
EP (1) EP1337548B1 (de)
CN (1) CN100491394C (de)
AT (1) ATE401337T1 (de)
AU (1) AU2002239366A1 (de)
CA (1) CA2426543C (de)
DE (1) DE60134885D1 (de)
WO (1) WO2002044328A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239366A1 (en) 2000-11-28 2002-06-11 Geetha Kassam Anti-angiogenic polypeptides
WO2003045323A2 (en) 2001-11-28 2003-06-05 Mediomics, Llc Anti-angiogenesis methods, compositions and uses therefor
CN100543036C (zh) * 2002-05-06 2009-09-23 得克萨斯州大学系统董事会 递送治疗或诊断试剂的导向蛋白质
EP1581164A4 (de) 2002-12-13 2008-03-12 Mediomics Llc Zusammensetzungen und verfahren zur hemmungvon tumorwachstum und metastasen
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors
CN101219219B (zh) * 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
AU647391B2 (en) * 1989-05-01 1994-03-24 University Of Notre Dame Du Lac, The Methods and materials for expression of human plasminogen in a eukaryotic cell system
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5945403A (en) 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US6057122A (en) * 1996-05-03 2000-05-02 Abbott Laboratories Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
JP2002510209A (ja) 1997-06-26 2002-04-02 カロリンスカ イノベイションズ アクチボラゲット インビボで血管形成を調節することができるプラスミノーゲンのクリングルドメイン１−５
WO1999013640A1 (fr) * 1997-09-11 1999-03-18 Sony Corporation Dispositif electronique
CA2303401A1 (en) 1997-10-01 1999-04-08 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
ES2272537T3 (es) 2000-09-01 2007-05-01 Philadelphia, Health And Education Corporation Metodos y composiciones para inhibir la angiogenesis.
AU2002239366A1 (en) 2000-11-28 2002-06-11 Geetha Kassam Anti-angiogenic polypeptides

Also Published As

Publication number Publication date
DE60134885D1 (de) 2008-08-28
CN100491394C (zh) 2009-05-27
US7626008B2 (en) 2009-12-01
US20040082030A1 (en) 2004-04-29
CA2426543A1 (en) 2002-06-06
AU2002239366A1 (en) 2002-06-11
US20090061510A1 (en) 2009-03-05
EP1337548A2 (de) 2003-08-27
CN1498223A (zh) 2004-05-19
WO2002044328A2 (en) 2002-06-06
WO2002044328A3 (en) 2003-04-03
CA2426543C (en) 2007-09-18
EP1337548A4 (de) 2005-01-12
EP1337548B1 (de) 2008-07-16
US7420036B2 (en) 2008-09-02

Similar Documents

Publication Publication Date Title
EP1083835A4 (de) Methoden und geräte zur vaskularen chirurgie
NO20034056D0 (no) Proliferative sykdommer
EP1465854A4 (de) Chalconderivate und deren verwendung zur behandlung von krankheiten
IL245955B (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
CO5611160A2 (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
DE60134885D1 (de) Antiangiogene polypeptide
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
TR200200278T2 (tr) Kalsilitik bileşimler
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
DK1303294T3 (da) Fremgangsmåde til behandling af instabil angina pectoris
NO20005548D0 (no) Mykobakterieinhibitorer
SI1276495T1 (sl) Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
PT1173194E (pt) Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares
TR200003084T2 (tr) Paroxetine askorbat
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties